HOB Biotech Group Corp.,Ltd (SHA:688656)

SHA:688656 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	67.23	121.63	163.47	153.8	449.86	58.82
Trading Asset Securities	-	-	-	135.23	5.01	-
Cash & Short-Term Investments	67.23	121.63	163.47	289.03	454.87	58.82
Cash Growth	-26.36%	-25.60%	-43.44%	-36.46%	673.38%	-35.20%
Accounts Receivable	54.49	48.61	41.5	32.38	37.48	29.9
Other Receivables	2.53	2.41	3.94	5.54	3.66	1.39
Receivables	57.01	51.02	45.44	37.92	41.15	31.29
Inventory	109.86	111.22	111.22	87.8	68.2	61.95
Prepaid Expenses	-	-	-	-	-	0.14
Other Current Assets	8.82	8.25	8.09	8.23	5.75	6.46
Total Current Assets	242.92	292.12	328.21	422.98	569.97	158.65
Property, Plant & Equipment	699.36	705.71	578.68	485.27	259.74	119.97
Other Intangible Assets	11.18	10.08	11.86	12.59	12.17	11.29
Long-Term Accounts Receivable	-	-	0.05	0.1	0.62	1.45
Long-Term Deferred Tax Assets	4.15	4.13	2.47	1.78	1.63	0.97
Long-Term Deferred Charges	14.61	12.12	11.58	16.25	10.27	2
Other Long-Term Assets	7.09	8.65	16.4	5.52	9.52	2.08
Total Assets	979.32	1,033	949.26	944.49	863.92	296.41
Accounts Payable	18.73	44.59	23.91	9.37	9.37	6.25
Accrued Expenses	22.86	37.98	34.98	31.06	29.4	22.34
Short-Term Debt	85.02	105.07	50.02	50.01	20.02	20.02
Current Portion of Leases	1.09	1.1	4.8	5.67	5.51	-
Current Income Taxes Payable	0.63	3.33	4.67	1.53	2.33	-
Current Unearned Revenue	12.16	14.45	14.62	13.33	13.54	9.08
Other Current Liabilities	5.4	3.42	2.74	41.89	6.01	5.53
Total Current Liabilities	145.9	209.94	135.75	152.86	86.17	63.23
Long-Term Debt	16	8	-	-	-	23.98
Long-Term Leases	1.11	1.53	1.03	9.74	5.35	-
Long-Term Unearned Revenue	1.99	1.2	1.74	2.49	2.4	2.81
Long-Term Deferred Tax Liabilities	-	-	-	0.04	0	-
Total Liabilities	164.99	220.67	138.52	165.13	93.92	90.02
Common Stock	63.48	63.06	63.06	63.06	63.06	47.29
Additional Paid-In Capital	571.25	562.98	553.46	550.62	549.35	68.65
Retained Earnings	199.31	205.82	193.92	165.51	157.49	90.32
Treasury Stock	-20.01	-20.01	-	-	-	-
Comprehensive Income & Other	0.29	0.29	0.29	0.18	0.1	0.13
Shareholders' Equity	814.32	812.14	810.73	779.36	770	206.39
Total Liabilities & Equity	979.32	1,033	949.26	944.49	863.92	296.41
Total Debt	103.22	115.69	55.86	65.43	30.88	44
Net Cash (Debt)	-35.99	5.93	107.61	223.6	423.99	14.81
Net Cash Growth	-	-94.49%	-51.88%	-47.26%	2762.22%	-63.59%
Net Cash Per Share	-0.56	0.09	1.68	3.54	6.89	0.31
Filing Date Shares Outstanding	62.68	62.26	62.72	63.06	63.06	47.29
Total Common Shares Outstanding	62.68	62.26	63.06	63.06	63.06	47.29
Working Capital	97.02	82.18	192.46	270.12	483.8	95.43
Book Value Per Share	12.99	13.04	12.86	12.36	12.21	4.36
Tangible Book Value	803.14	802.06	798.87	766.77	757.83	195.1
Tangible Book Value Per Share	12.81	12.88	12.67	12.16	12.02	4.13
Buildings	512.47	1.25	20.53	20.53	17.34	17.34
Machinery	362.11	848.29	249.06	214.57	167.93	126.92
Construction In Progress	0.1	4.83	422.97	325.75	128.88	24.86

Source: S&P Global Market Intelligence. Standard template. Financial Sources.